Global Diabetic Neuropathy Drugs Market 2019-2023| Development of Novel Biologics to Boost Growth | Technavio

LONDON–(BUSINESS WIRE)–lt;a href=”” target=”_blank”gt;#Researchlt;/agt;–The global diabetic neuropathy drugs market is expected to post a CAGR
of more than 6% during the period 2019-2023, according to the latest
market research report by Technavio.

The prevalence of diabetic neuropathy is increasing at a rapid pace,
resulting in the growing need for disease-modifying drugs for the
treatment of this disease. As a result, several top players are
developing new drugs, and many of these drugs are being approved in the
market. For instance, in September 2015, capsaicin 8% cutaneous patch
(Qutenza) was approved. Hence, with new drug approvals and strong drug
pipeline, the market is expected to grow during the forecast period.

As per Technavio, the development of novel biologics to treat diabetic
neuropathy will have a positive impact on the market and contribute to
its growth significantly over the forecast period. This global
diabetic neuropathy drugs market 2019-2023
report also analyzes other important trends and market drivers that will
affect market growth over 2019-2023.

Global diabetic neuropathy drugs market:
Development of novel biologics to treat diabetic neuropathy

With the significant increase in the prevalence of diabetic neuropathy,
the established players in the market are continually focusing on the
development of novel biologics for the treatment of the disease. For
instance, vendors are in the process of developing drugs for the
treatment of diabetic foot ulcers and diabetic neuropathies. Currently,
such drugs are in different phases of clinical trials for diabetic
peripheral neuropathy, peripheral arterial disorders, and diabetic foot
ulcer in the US. The development of novel biologics to treat diabetic
neuropathy will drive the growth of the diabetic neuropathy market
during the forecast period.

“Diabetic neuropathy is the most common complication associated with
diabetes. Therefore, creating awareness among the population about
diabetes and its related complications has become very important. Hence,
several programs are being initiated by many countries across the world
to bring awareness regarding diabetics. For instance, in India, the
National Diabetes Educator Program was initiated with the primary aim to
educate and train diabetes educators in the country. Such initiatives
will directly impact the growth of the diabetic neuropathy drugs market
during the forecast period,”
says a senior research analyst at

Global diabetic neuropathy drugs market:
Segmentation analysis

This market research report segments the global diabetic neuropathy
drugs market by the mechanism of action (calcium channel alpha-2-delta
ligand, SNRIs and TCAs, and others) and geographic regions (North
America, Europe, Asia, and ROW).

The North America region led the market in 2018, followed by Europe,
Asia, and ROW, respectively. The market growth in North America can be
attributed to the growing prevalence of diabetes, which has led to an
increase in the prevalence of diabetic neuropathy in the region.

Looking for more information on this market? Request
a free sample report

Technavio’s sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

Market Sizing

  • Market definition
  • Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

  • Regional comparison
  • Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Competitive scenario

About Technavio

is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio’s comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team


Technavio Research
Jesse Maida
Media & Marketing Executive
+1 844 364 1100
UK: +44 203 893 3200